Literature DB >> 7619991

Clearance of funguria with short-course antifungal regimens: a prospective, randomized, controlled study.

H S Leu1, C T Huang.   

Abstract

The effects of short-course antifungal regimens on funguria were studied in 180 hospitalized adults who did not have ascending urinary or deep fungal infections but did have > 1,000 cfu of yeast/mL in two consecutive urine cultures. Before treatment, efforts were made to eliminate factors conducive to funguria. No additional interventions were implemented in the management of the control group (group A), whereas five experimental groups received short-course therapy as follows: oral administration of fluconazole (group B); single-dose intravenous administration of amphotericin B (group C); and intermittent bladder irrigation with amphotericin B at low, medium, and high concentrations (groups D, E, and F, respectively). Urine was cultured on days 1 and 7 after antifungal treatment. The rate of spontaneous clearance of funguria in the control group was 40.0%. Rates of clearance in experimental groups B through F were 58.6%, 55.2%, 82.1% (P < .01), 86.7% (P < .001), and 83.3% (P < .001), respectively, on day 1 and 77.3% (P < .01), 72.0% (P < .05), 42.9%, 68.4%, and 68.2% (P < .05), respectively, on day 7. The decrement in yeast count was 60.8% for the control group. Decrements for experimental groups B through F were 80.5%, 74.2%, 94.2% (P < .01), 86.7% (P < .05), and 95.3% (P < .001), respectively, on day 1 and 85.5% (P < .05), 80.7%, 75.7%, 87.9% (P < .05), and 76.4%, respectively, on day 7.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619991     DOI: 10.1093/clinids/20.5.1152

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Candiduria: When and How to Treat It.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

2.  The mold conundrum in chronic hyperplastic sinusitis.

Authors:  Fenna A Ebbens; Christos Georgalas; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

3.  [Effect of bladder irrigation with amphotericin B for treatment of urinary tract fungal infection: a meta-analysis].

Authors:  Yuan-Yuan Xiang; Yu Lv; Ren Guo; Juan Xue
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

Review 4.  Treatment of systemic fungal infections in older patients: achieving optimal outcomes.

Authors:  C A Kauffman; S A Hedderwick
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 5.  Antifungal agents in the 1990s. Current status and future developments.

Authors:  C A Kauffman; P L Carver
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

6.  Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hosts.

Authors:  A Velegraki; D Papalambrou; S Soremi; N J Legakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

7.  Unexpected candidemia complicating ureteroscopy and urinary stenting.

Authors:  M Gross; H Winkler; S Pitlik; M Weinberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

Review 8.  Fungal urinary tract infections in the elderly: treatment guidelines.

Authors:  L G Jacobs
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

9.  Complicated urinary tract infection in adults.

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

Review 10.  The mold conundrum in chronic rhinosinusitis: where do we stand today?

Authors:  Fenna A Ebbens; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.